|
CONCURRENT USE MAY ENHANCE THE POTENTIAL FOR RENAL TOXICITY, BRONCHOSPASM, AND HYPOTENSION
|
IN VITRO INACTIVATION OF AMINOGLYCOSIDES WHEN RECONSTITUTED WITH UNASYN
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ANTIHISTAMINES LIKE CHLORPHENIRAMINE MAY MASK THE OTOTOXICITY PRODUCED BY AMINOGLYCOSIDES
|
ANTIHISTAMINES LIKE CHLORPHENIRAMINE MAY MASK THE OTOTOXICITY PRODUCED BY AMINOGLYCOSIDES
|
ANTIHISTAMINES LIKE CHLORPHENIRAMINE MAY MASK THE OTOTOXICITY PRODUCED BY AMINOGLYCOSIDES
|
ANTIHISTAMINES LIKE CHLORPHENIRAMINE MAY MASK THE OTOTOXICITY PRODUCED BY AMINOGLYCOSIDES
|
ANTIHISTAMINES LIKE CHLORPHENIRAMINE MAY MASK THE OTOTOXICITY PRODUCED BY AMINOGLYCOSIDES
|
ANTIHISTAMINES LIKE CHLORPHENIRAMINE MAY MASK THE OTOTOXICITY PRODUCED BY AMINOGLYCOSIDES
|
ANTIHISTAMINES LIKE CHLORPHENIRAMINE MAY MASK THE OTOTOXICITY PRODUCED BY AMINOGLYCOSIDES
|
ANTIHISTAMINES LIKE CHLORPHENIRAMINE MAY MASK THE OTOTOXICITY PRODUCED BY AMINOGLYCOSIDES
|
ANTIHISTAMINES LIKE CHLORPHENIRAMINE MAY MASK THE OTOTOXICITY PRODUCED BY AMINOGLYCOSIDES
|
ANTIHISTAMINES LIKE CHLORPHENIRAMINE MAY MASK THE OTOTOXICITY PRODUCED BY AMINOGLYCOSIDES
|
ANTIHISTAMINES LIKE CHLORPHENIRAMINE MAY MASK THE OTOTOXICITY PRODUCED BY AMINOGLYCOSIDES
|
ANTIHISTAMINES LIKE CHLORPHENIRAMINE MAY MASK THE OTOTOXICITY PRODUCED BY AMINOGLYCOSIDES
|
ANTIHISTAMINES LIKE CHLORPHENIRAMINE MAY MASK THE OTOTOXICITY PRODUCED BY AMINOGLYCOSIDES
|
ANTIHISTAMINES LIKE CHLORPHENIRAMINE MAY MASK THE OTOTOXICITY PRODUCED BY AMINOGLYCOSIDES
|
ANTIHISTAMINES LIKE CHLORPHENIRAMINE MAY MASK THE OTOTOXICITY PRODUCED BY AMINOGLYCOSIDES
|
ANTIHISTAMINES LIKE CHLORPHENIRAMINE MAY MASK THE OTOTOXICITY PRODUCED BY AMINOGLYCOSIDES
|
ANTIHISTAMINES LIKE CHLORPHENIRAMINE MAY MASK THE OTOTOXICITY PRODUCED BY AMINOGLYCOSIDES
|
ANTIHISTAMINES LIKE CHLORPHENIRAMINE MAY MASK THE OTOTOXICITY PRODUCED BY AMINOGLYCOSIDES
|
ANTIHISTAMINES LIKE CHLORPHENIRAMINE MAY MASK THE OTOTOXICITY PRODUCED BY AMINOGLYCOSIDES
|
ANTIHISTAMINES LIKE CHLORPHENIRAMINE MAY MASK THE OTOTOXICITY PRODUCED BY AMINOGLYCOSIDES
|
ANTIHISTAMINES LIKE CHLORPHENIRAMINE MAY MASK THE OTOTOXICITY PRODUCED BY AMINOGLYCOSIDES
|
ANTIHISTAMINES LIKE CHLORPHENIRAMINE MAY MASK THE OTOTOXICITY PRODUCED BY AMINOGLYCOSIDES
|
ANTIHISTAMINES LIKE CHLORPHENIRAMINE MAY MASK THE OTOTOXICITY PRODUCED BY AMINOGLYCOSIDES
|
ANTIHISTAMINES LIKE CHLORPHENIRAMINE MAY MASK THE OTOTOXICITY PRODUCED BY AMINOGLYCOSIDES
|
ANTIHISTAMINES LIKE CHLORPHENIRAMINE MAY MASK THE OTOTOXICITY PRODUCED BY AMINOGLYCOSIDES
|
ANTIHISTAMINES LIKE CHLORPHENIRAMINE MAY MASK THE OTOTOXICITY PRODUCED BY AMINOGLYCOSIDES
|
ANTIHISTAMINES LIKE CHLORPHENIRAMINE MAY MASK THE OTOTOXICITY PRODUCED BY AMINOGLYCOSIDES
|
ANTIHISTAMINES LIKE CHLORPHENIRAMINE MAY MASK THE OTOTOXICITY PRODUCED BY AMINOGLYCOSIDES
|
ANTIHISTAMINES LIKE CHLORPHENIRAMINE MAY MASK THE OTOTOXICITY PRODUCED BY AMINOGLYCOSIDES
|
ADDITIVE ACTIVITY OFTEN RESULTS WHEN QUINOLONES ARE COMBINED WITH AMINOGLYCOSIDES
|
ADDITIVE ACTIVITY OFTEN RESULTS WHEN QUINOLONES ARE COMBINED WITH AMINOGLYCOSIDES
|
ADDITIVE ACTIVITY OFTEN RESULTS WHEN QUINOLONES ARE COMBINED WITH AMINOGLYCOSIDES
|
ADDITIVE ACTIVITY OFTEN RESULTS WHEN QUINOLONES ARE COMBINED WITH AMINOGLYCOSIDES
|
ADDITIVE ACTIVITY OFTEN RESULTS WHEN QUINOLONES ARE COMBINED WITH AMINOGLYCOSIDES
|
ADDITIVE ACTIVITY OFTEN RESULTS WHEN QUINOLONES ARE COMBINED WITH AMINOGLYCOSIDES
|
ADDITIVE ACTIVITY OFTEN RESULTS WHEN QUINOLONES ARE COMBINED WITH AMINOGLYCOSIDES
|
ADDITIVE ACTIVITY OFTEN RESULTS WHEN QUINOLONES ARE COMBINED WITH AMINOGLYCOSIDES
|
ADDITIVE ACTIVITY OFTEN RESULTS WHEN QUINOLONES ARE COMBINED WITH AMINOGLYCOSIDES
|
INCREASED RISK OF NEPHROTOXICITY & OTOTOXICITY
|
INCREASED RISK OF NEPHROTOXICITY & OTOTOXICITY
|
INCREASED RISK OF NEPHROTOXICITY & OTOTOXICITY
|
INCREASED RISK OF NEPHROTOXICITY & OTOTOXICITY
|
INCREASED RISK OF NEPHROTOXICITY & OTOTOXICITY
|
INCREASED RISK OF NEPHROTOXICITY & OTOTOXICITY
|
INCREASED RISK OF NEPHROTOXICITY & OTOTOXICITY
|
INCREASED RISK OF NEPHROTOXICITY & OTOTOXICITY
|
INCREASED RISK OF NEPHROTOXICITY & OTOTOXICITY
|
INCREASED RISK OF NEPHROTOXICITY & OTOTOXICITY
|
INCREASED RISK OF NEPHROTOXICITY & OTOTOXICITY
|
INCREASED RISK OF NEPHROTOXICITY & OTOTOXICITY
|
INCREASED RISK OF NEPHROTOXICITY & OTOTOXICITY
|
INCREASED RISK OF NEPHROTOXICITY & OTOTOXICITY
|
INCREASED RISK OF NEPHROTOXICITY & OTOTOXICITY
|
|
|
|
|
|
|
|
|
|
MUCOPOLYSACCHARIDE POLYSULFATE IS INCOMPATIBLE WITH AMINOGLYCOSIDES
|
NEUROMUSCULAR BLOCKING EFFECT OF MAGNESIUM SALT, AMINOGLYCOSIDES & NIFEDEPINE MAY BE ADDITIVE
|
NEUROMUSCULAR BLOCKING EFFECT OF MAGNESIUM SALT, AMINOGLYCOSIDES & NIFEDEPINE MAY BE ADDITIVE
|
NEUROMUSCULAR BLOCKING EFFECT OF MAGNESIUM SALT, AMINOGLYCOSIDES & NIFEDEPINE MAY BE ADDITIVE
|
NEUROMUSCULAR BLOCKING EFFECT OF MAGNESIUM SALT, AMINOGLYCOSIDES & NIFEDEPINE MAY BE ADDITIVE
|
HYALURONIDASE EFFECT IS INHIBITED BY THE DRUG
|
AMINOGLYCOSIDES LIKE DRUGS OTOTOXICITY MAY BE MASKED BY THE DRUG
|
SYNERGISTIC ACTION BUT INCREASED CHANCES OF NEPHROTOXICITY
|
SYNERGISTIC ACTION BUT INCREASED CHANCES OF NEPHROTOXICITY
|
SYNERGISTIC ACTION BUT INCREASED CHANCES OF NEPHROTOXICITY
|
SYNERGISTIC ACTION BUT INCREASED CHANCES OF NEPHROTOXICITY
|
SYNERGISTIC ACTION BUT INCREASED CHANCES OF NEPHROTOXICITY
|
SYNERGISTIC ACTION BUT INCREASED CHANCES OF NEPHROTOXICITY
|
SYNERGISTIC ACTION BUT INCREASED CHANCES OF NEPHROTOXICITY
|
SYNERGISTIC ACTION BUT INCREASED CHANCES OF NEPHROTOXICITY
|
SYNERGISTIC ACTION BUT INCREASED CHANCES OF NEPHROTOXICITY
|
SYNERGISTIC ACTION BUT INCREASED CHANCES OF NEPHROTOXICITY
|
SYNERGISTIC ACTION BUT INCREASED CHANCES OF NEPHROTOXICITY
|
SYNERGISTIC ACTION BUT INCREASED CHANCES OF NEPHROTOXICITY
|
SYNERGISTIC ACTION BUT INCREASED CHANCES OF NEPHROTOXICITY
|
SYNERGISTIC ACTION BUT INCREASED CHANCES OF NEPHROTOXICITY
|
SYNERGISTIC ACTION BUT INCREASED CHANCES OF NEPHROTOXICITY
|
SYNERGISTIC ACTION BUT INCREASED CHANCES OF NEPHROTOXICITY
|